| Nurses’ perceptions of and satisfaction with the use of automated dispensing cabinets at the Heart and Cancer Centers in Qatar: a cross-sectional study M Zaidan, F Rustom, N Kassem, S Al Yafei, L Peters, MIM Ibrahim BMC nursing 15, 1-8, 2016 | 42 | 2016 |
| Jadenu® substituting Exjade® in iron overloaded β-thalassemia major (BTM) patients: a preliminary report of the effects on the tolerability, serum ferritin level, liver iron … MA Yassin, AT Soliman, V De Sanctis, RM Hussein, R Al-Okka, N Kassem, ... Mediterranean journal of hematology and infectious diseases 10 (1), 2018 | 32 | 2018 |
| Population pharmacokinetics of intravenous methotrexate in patients with hematological malignancies: utilization of routine clinical monitoring parameters A Nader, N Zahran, A Alshammaa, H Altaweel, N Kassem, KJ Wilby European journal of drug metabolism and pharmacokinetics 42, 221-228, 2017 | 32 | 2017 |
| Effects of intermittent fasting on response to tyrosine kinase inhibitors (TKIS) in patients with chronic myeloid leukemia: an outcome of european leukemianet project MA Yassin, RS Ghasoub, MB Aldapt, MA Abdulla, P Chandra, ... Cancer Control 28, 10732748211009256, 2021 | 29 | 2021 |
| How I treat obesity and obesity related surgery in patients with chronic myeloid leukemia: an outcome of an ELN project MA Yassin, N Kassem, R Ghassoub Clinical Case Reports 9 (3), 1228-1234, 2021 | 18 | 2021 |
| Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar MYAH Nabil E Omar, Shereen Elazzazy , Oraib Abdallah, Abdulqadir J Nashwan ... Journal of Oncology Pharmacy Practice, 2019 | 18* | 2019 |
| Chronic myeloid leukemia in adolescents and young adults: a single institute experience MA Yassin, MAJ Abdulla, P Chandra, MB Aldapt, Y Hamad, SJ Akiki, ... Blood 134, 5915, 2019 | 9 | 2019 |
| Outcome of pregnancy in the era of pegylated interferon-α2a in females with chronic myeloid leukemia: An experience from qatar M Abu-Tineh, N Kassem, MAJ Abdulla, OM Ismail, K Obeidat, R Ghasoub, ... Case Reports in Oncology 13 (1), 291-294, 2020 | 6 | 2020 |
| Second generation tyrosisne kinase inhibitors as upfront therapy in the era of sleeve gastrectomy does it work? MA Yassin, A Nashwan, N Kassem Blood, The Journal of the American Society of Hematology 130 (Suppl_1), 5260 …, 2017 | 6 | 2017 |
| Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis MA Yassin, MOA Rahman, AA Hamad, AR Poil, MT Abdelrazek, ... Medicine 99 (51), e23637, 2020 | 5 | 2020 |
| Acute myeloid leukemia in qatar (2010–2016): clinical, biological, and prognostic factors and treatment outcomes H El Omri, RY Taha, A Elomri, N Kacem, H Elsabah, AY Ellahie, A Gamil, ... Frontiers in Genetics 11, 553, 2020 | 5 | 2020 |
| Outcome of pregnancy in the era of pegylated interferon alpha 2a in females with essential thrombocythemia: an experience from Qatar M Abu-Tineh, N Kassem, MAJ Abdulla, OM Ismail, R Ghasoub, MB Aldapt, ... Case Reports in Oncology 13 (1), 336-340, 2020 | 4 | 2020 |
| Nilotinib Induced Recurrent Gastric Polyps: Case Report and Review of Literature N Kassem, OM Ismail, H Elomri, MA Yassin The American journal of case reports 18, 794, 2017 | 4 | 2017 |
| Clinico-pathological profiles of obese patients with chronic myeloid leukemia (CML) and their response to therapies (TKIs) MA Yassin, MAJ Abdulla, F Abbas, P Chandra, AJ Nashwan, RS Ghasoub, ... Blood 134, 5912, 2019 | 3 | 2019 |
| PB1997: daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: outcome and safety profile from a real-world single … H Elsabah, N Kassem, A Gulied, R Taha, H Elomri, H Cherif HemaSphere 6, 1868-1869, 2022 | 2 | 2022 |
| Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: a protocol for systematic review and meta-analysis N Kassem, AA Ghazy, M Abu-Tineh, NE Omar, AJ Nashwan, P Chandra, ... Medicine 99 (51), e23632, 2020 | 2 | 2020 |
| Effects of Ramadan fasting in patients with chronic myeloid leukemia in chronic phase MA Yassin, RS Ghasoub, MB Aldapt, MAJ Abdulla, P Chandra, ... Blood 134, 5907, 2019 | 2 | 2019 |
| Jadenu substituting Exjade in beta thalassemia major (BTM) patients with iron overload: effect on serum ferritin concentration, liver iron content and biochemical profiles MA Yassin, A Nashwan, N Kassem, AT Soliman, V De Sanctis, AA Adel, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 2 | 2018 |
| Diagnostic delay and associated clinical features of tuberculosis among adult patients with acute myeloid leukemia in Doha, Qatar H El Omri, R Taha, W Ibrahim, N Kassem, L Szabados, H El Sabah, ... Journal of Tuberculosis Research 6 (1), 49-62, 2018 | 2 | 2018 |
| Cutaneous manifestations of nilotinib MA Yassin, D Mudawi, A Nashwan, N Kassem Int J Blood Res Disord 3, 1-3, 2018 | 2 | 2018 |
Mohamed A . Yassin,MDProfessor of Hematology ,Head of Hematology ,Hamad Medical Corporation,CMED QUGeverifieerd e-mailadres voor hamad.qa
